XON - Intrexon Corporation

NYSE - NYSE Delayed Price. Currency in USD

Intrexon Corporation

20374 Seneca Meadows Parkway
Germantown, MD 20876
United States
301-556-9900
http://www.dna.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees832

Key Executives

NameTitlePayExercisedAge
Mr. Randal J. Kirk J.D.Chairman and Chief Exec. OfficerN/A313.18k64
Mr. Rick L. SterlingChief Financial Officer372.6k73.71k53
Dr. Andrew J. Last Ph.D.Chief Operating Officer195.07kN/A57
Mr. Nir NimrodiSr. VP of Corp. Devel.520.95kN/A48
Dr. Thomas D. Reed Ph.D.Founder and Chief Science OfficerN/AN/A51
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor-altering chemical or antioxidant additives; commercial aquaculture products; and artwork, children's toys, and novelty goods that are derived from living organisms or enabled by synthetic biology. The company serves health, food, energy, environment, and consumer sectors. Intrexon Corporation has collaboration and license agreements with Ares Trading S.A.; ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Thrive Agrobiotics, Inc.; Intrexon Energy Partners II, LLC; and others. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.

Corporate Governance

Intrexon Corporation’s ISS Governance QualityScore as of October 15, 2017 is 3. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 2; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.